Lee et al.
JOCArticle
13C NMR (CDCl3, 125 MHz) δ 20.2, 21.6, 52.4, 81.5, 92.6,
112.9, 119.4, 128.7, 128.9, 129.3, 130.9, 132.7, 135.7, 139.8,
145.1, 152.9; IR νCO (CHCl3) 1664.0 cm-1; HRMS (EI) calcd
for C20H19N1O3S1 (Mþ) 353.1086, found 353.1089.
5-Methyl-7-phenyl-3-tosyl-3-aza-bicyclo[3.2.0]hept-6-en-2-one
(11): 1H NMR (CDCl3, 500 MHz) δ 1.43 (s, 3 H), 2.40 (s, 3 H),
3.44 (s, 1 H), 3.59 (d, J = 10.5 Hz, 1 H), 4.06 (d, J = 10.5 Hz, 1
H), 6.47 (s, 1 H), 7.27 (d, J = 6.8 Hz, 2 H), 7.32 (m, 3 H), 7.46 (m,
2 H), 7.90 (d, J = 6.8 Hz, 2 H); 13C NMR (CDCl3, 125 MHz) δ
21.6 (2 C), 40.1, 54.1, 54.9, 125.3, 128.1, 128.4, 128.8, 129.5,
131.8, 133.5, 134.9, 145.0, 146.2, 172.3; IR νCO (CHCl3) 1726.4
cm-1; HRMS (EI) calcd for C20H19N1O3S1 (Mþ) 353.1086,
found 353.1088.
cm-1; HRMS (EI) calcd for C14H14O2 (Mþ) 214.0994, found
214.0996.
5-Methyl-7-p-tolyl-3-oxa-bicyclo[3.2.0]hept-6-en-2-one (20):
1H NMR (CDCl3, 500 MHz) δ 1.48 (s, 3 H), 2.34 (s, 3 H),
3.52 (s, 1 H), 4.09 (d, J = 9.6 Hz, 1 H), 4.33 (d, J = 9.6 Hz, 1 H),
6.45 (s, 1 H), 7.16 (d, J = 7.9 Hz, 2 H), 7.42 (d, J = 7.9 Hz, 2 H);
13C NMR (CDCl3, 125 MHz) δ 20.3, 21.4, 44.8, 51.2, 74.7,
125.1, 129.2 (2 C), 132.4, 139.0, 146.0, 175.6; IR νCO (CHCl3)
1747.2 cm-1; HRMS (EI) calcd for C14H14O2 (Mþ: 214.0994,
found 214.0993.
(E)-2-Methylbut-2-enyl 3-phenylpropiolate (21): 1H NMR
(CDCl3, 500 MHz) δ 1.66 (dq, J = 1.0, 10 Hz, 3 H), 1.72 (q, J
= 1.0 Hz, 3 H), 4.62 (s, 2 H), 5.64 (m, 1 H), 7.37 (m, 2 H), 7.45
(m, 1 H), 7.59 (m, 2 H); 13C NMR (CDCl3, 125 MHz) δ 13.3,
13.7, 71.9, 80.6, 86.2, 119.7, 125.6, 128.5, 139.9, 130.6, 133.0,
154.1; IR νCO (CHCl3) 1700.8 cm-1; HRMS (EI) calcd for
C14H14O2 (Mþ) 214.0994, found 214.0991.
1
N-(But-2-enyl)-3-phenyl-N-tosylpropiolamide (12): H NMR
(CDCl3, 500 MHz) δ 1.73 (trans) (d, J = 6.3 Hz, 3 H), 1.8 (cis)
(d, J = 6.9 Hz, 3 H), 2.41 (s, 3 H), 4.62 (trans) (d, J = 6.0 Hz, 2
H), 4.75 (cis) (d, J = 6.4 Hz, 2 H), 5.55 (cis) (m, 1 H), 5.62 (trans)
(m, 1 H), 5.73 (cis) (m, 1 H), 5.86 (trans) (m, 1 H), 7.29 (d, J = 7.1
Hz, 2 H), 7.38 (m, 2 H), 7.46 (m, 1 H), 7.51 (m, 2 H), 7.89 (d, J =
7.1 Hz, 2 H); 13C NMR (CDCl3, 125 MHz) δ 17.6, 21.5, 48.9,
81.6, 92.7, 119.4, 125.2, 128.6, 129.2, 129.3, 130.8, 130.9, 132.6,
136.0, 144.9, 152.5; IR νCO (CHCl3) 1660.8 cm-1; HRMS (EI)
calcd for C20H19N1O3S1 (Mþ) 353.1086, found 353.1089.
6-Methyl-7-phenyl-3-tosyl-3-aza-bicyclo[3.2.0]hept-6-en-2-one
(13): 1H NMR (CDCl3, 500 MHz) δ 2.07 (s, 3 H), 2.40 (s, 3 H),
3.19 (dd, J = 3.9, 8.3 Hz, 1 H), 3.69 (m, 1 H), 3.77 (d, J = 8.3,
10.6 Hz, 1 H), 4.04 (d, J = 10.6 Hz, 1 H), 7.23 (m, 1 H), 7.27 (d, J
= 8.0 Hz, 2 H), 7.31 (m, 2 H), 7.43 (m, 2 H), 7.89 (d, J = 8.3 Hz,
2 H); 13C NMR (CDCl3, 125 MHz) δ 13.9, 21.6, 35.7, 46.5, 47.4,
126.3, 127.8, 128.1, 128.4, 129.5, 133.1, 135.0, 140.3, 140.8,
145.0, 172.5; IR νCO (CHCl3) 1728.0 cm-1; HRMS (EI) calcd
for C20H19N1O3S1 (Mþ) 353.1086, found 353.1089.
5,6-Dimethyl-7-phenyl-3-oxa-bicyclo[3.2.0]hept-6-en-2-one (22):
1H NMR (CDCl3, 500 MHz) δ 1.44 (s, 3 H), 2.04 (d, J = 1.8 Hz,
3 H), 3.45 (q, J = 1.8 Hz, 1 H), 4.00 (d, J = 9.7 Hz, 1 H), 4.33 (d,
J = 9.7 Hz, 1 H), 7.27 (m, 1 H), 7.37 (m, 2 H), 7.53 (m, 2 H); 13
C
NMR (CDCl3, 125 MHz) δ 11.5, 18.3, 46.2, 49.9, 72.4, 126.2,
127.8, 128.5, 133.2, 137.9, 144.5, 176.0; IR νCO (CHCl3) 1752.8
cm-1; HRMS (EI) calcd for C14H14O2 (Mþ) 214.0994, found
214.0992.
(E)-2-Methylbut-2-enyl 3-p-tolylpropiolate (23): 1H NMR
(CDCl3, 300 MHz) δ 1.66 (d, J = 6.6 Hz, 3 H), 1.71 (s, 3 H),
2.38 (s, 3 H), 4.61 (s, 2 H), 5.63 (q, J = 6.6 Hz, 2 H), 7.17 (d, J =
8.1 Hz, 2 H), 7.48 (d, J = 8.1 Hz, 2 H); 13C NMR (CDCl3, 75
MHz) δ 13.3, 13.7, 21.7, 71.8, 80.3, 86.7, 116.6, 125.5, 129.3,
130.0, 133.0, 141.2, 154.2; IR νCO (CHCl3) 1696.8 cm-1; HRMS
(EI) calcd for C15H16O2 (Mþ) 228.1150, found 228.1151.
5,6-Dimethyl-7-p-tolyl-3-oxa-bicyclo[3.2.0]hept-6-en-2-one (24):
1H NMR (CDCl3, 500 MHz) δ 1.42 (s, 3 H), 2.01 (d, J = 1.8 Hz,
3 H), 2.34 (s, 3 H), 3.41 (q, J = 1.8 Hz, 1 H), 3.99 (d, J = 9.6 Hz,
1 H), 4.31 (d, J = 9.6 Hz, 1 H), 7.17 (d, J = 8.0 Hz, 2 H), 7.41 (d,
J = 8.0 Hz, 2 H); 13C NMR (CDCl3, 125 MHz) δ 11.5, 18.4, 21.3,
46.2, 49.9, 72.5, 126.1, 129.2, 130.5, 137.8, 137.9, 143.2, 176.2; IR νCO
(CHCl3) 1748.8 cm-1; HRMS (EI) calcd for C15H16O2 (Mþ)
228.1150, found 228.1149.
But-2-enyl 3-p-tolylpropiolate (14): 1H NMR (CDCl3, 500
MHz) δ 1.75 (d, J = 6.5 Hz, 3 H), 2.38 (s, 3 H), 4.65 (trans) (d, J
= 6.7 Hz, 2 H), 4.80 (cis) (d, J = 7.0 Hz, 2 H), 5.62 (cis) (m, 1 H),
5.65 (trans) (m, 1 H), 5.79 (cis) (m, 1 H), 5.88 (trans) (m, 1 H),
7.17 (d, J = 8.0 Hz, 2 H), 7.47 (d, J = 8.0 Hz, 2 H); 13C NMR
(CDCl3, 125 MHz) δ 21.6, 21.7, 66.6, 80.2, 86.8, 116.5, 124.2,
129.3, 132.7, 133.0, 141.2, 154.0; IR νCO (CHCl3) 1705.6 cm-1
;
HRMS (EI) calcd for C14H14O2 (Mþ) 214.0994, found 214.0995.
6-Methyl-7-p-tolyl-3-oxa-bicyclo[3.2.0]hept-6-en-2-one (15):
1H NMR (CDCl3, 500 MHz) δ 2.07 (t, J = 1.5 Hz, 3 H), 2.34
(s, 3 H), 3.43 (m, 1 H), 3.80 (dq, J = 1.7, 3.6 Hz, 1 H), 4.33 (m, 2
H), 7.17 (d, J = 8.2 Hz, 2 H), 7.42 (d, J = 8.2 Hz, 2 H); 13C
NMR (CDCl3, 125 MHz) δ 14.0, 21.3, 40.6, 43.5, 67.5, 126.1,
129.2, 130.4, 137.9, 139.8, 140.1, 175.8; IR νCO (CHCl3) 1746.4
cm-1; HRMS (EI) calcd for C14H14O2 (Mþ) 214.0994, found
214.0996.
N-(Cyclohexenylmethyl)-3-phenyl-N-tosylpropiolamide (25):
1H NMR (CDCl3, 500 MHz) δ 1.58 (m, 4 H), 1.93 (m, 2 H),
2.06 (m, 2 H), 2.43 (s, 3 H), 4.61 (s, 2 H), 5.77 (m, 1 H), 7.30 (d, J
= 8.2 Hz, 2 H), 7.38 (m, 2 H), 7.46 (m, 1 H), 7.51 (m, 2 H), 7.91
(d, J = 8.2 Hz, 2 H); 13C NMR (CDCl3, 125 MHz) δ 21.7, 22.1,
22.4, 25.0, 26.1, 52.9, 81.7, 92.7, 119.5, 125.7, 128.7, 128.9, 129.2,
130.9, 132.3, 132.7, 135.9, 144.9, 153.1; IR νCO (CHCl3) 1660.8
cm-1; HRMS (FAB) calcd for C23H24N1O3S1 ([M þ H]þ)
394.1477, found 394.1480.
2-Tosyl-4-phenylbenzo[1,4]cyclobuta[1,2-c]pyrrole-3(3aH)-one,
pentahydro (26): 1H NMR (CDCl3, 500 MHz) δ 1.35 (m, 2 H),
1.67 (m, 1 H), 1.77 (m, 1 H), 1.98 (m, 1 H), 2.03 (m, 1 H), 2.30 (m,
1 H), 2.40 (s, 3 H), 2.81 (m, 1 H), 3.43 (d, J = 2.3 Hz, 1 H), 3.52
(d, J = 10.2 Hz, 1 H), 4.17 (d, J = 10.2 Hz, 1 H), 7.22 (m, 1 H),
7.28 (d, J = 8.2 Hz, 2 H), 7.31 (m, 2 H), 7.41 (m, 2 H), 7.90 (d, J
= 8.2 Hz, 2 H); 13C NMR (CDCl3, 125 MHz) δ 21.7, 22.5, 24.6,
26.2, 35.4, 39.9, 52.2, 53.9, 126.2, 127.7, 128.1, 128.4, 129.5,
133.2, 135.0, 135.4, 144.9, 147.4, 172.6; IR νCO (CHCl3) 1716.0
cm-1; HRMS (FAB) calcd for C23H24N1O3S1 ([M þ H]þ)
394.1477, found 394.1478.
(E)-3-(1-p-Tolylprop-1-enyl)furan-2(5H)-one (16): 1H NMR
(CDCl3, 500 MHz) δ 1.67 (d, J = 7.0 Hz, 3 H), 2.39 (s, 3 H), 4.71
(m, 1 H), 4.72 (m, 1 H), 6.69 (m, 1 H), 7.04 (d, J = 7.9 Hz, 2 H),
7.21 (d, J = 7.9 Hz, 2 H), 7.22 (q, J = 7.0 Hz, 1 H); 13C NMR
(CDCl3, 125 MHz) δ 15.3, 21.2, 68.9, 129.1, 129.2, 129.6, 132.3,
132.5, 135.0, 137.0, 144.1, 172.0; IR νCO (CHCl3) 1733.6 cm-1
;
HRMS (EI) calcd for C14H14O2 (Mþ) 214.0994, found 214.0998.
5-Methyl-7-phenyl-3-oxa-bicyclo[3.2.0]hept-6-en-2-one (18):
1H NMR (CDCl3, 500 MHz) δ 1.49 (s, 3 H), 3.55 (s, 1 H),
4.10 (d, J = 9.6 Hz, 1 H), 4.34 (d, J = 9.6 Hz, 1 H), 6.52 (s, 1 H),
7.30 (m, 1 H), 7.36 (m, 2 H), 7.53 (m, 2 H); 13C NMR (CDCl3,
125 MHz) δ 20.2, 44.9, 51.3, 74.6, 125.2, 128.5, 128.9, 131.9,
133.6, 146.1, 175.4; IR νCO (CHCl3) 1766.4 cm-1; HRMS (EI)
calcd for C13H12O2 (Mþ) 200.0837, found 200.0839.
Cyclohexenylmethyl-3-phenylpropiolate (27): 1H NMR
(CDCl3, 500 MHz) δ 1.61 (m, 2 H), 1.69 (m, 2 H), 2.07 (m, 4
H), 4.61 (s, 2 H), 5.84 (m, 1 H), 7.38 (m, 2 H), 7.46 (m, 1 H), 7.60
(m, 2 H); 13C NMR (CDCl3, 125 MHz) δ 22.0, 22.3, 25.0, 25.9,
70.5, 80.6, 86.2, 119.7, 127.8, 128.5, 130.6, 132.1, 133.0, 154.1;
IR νCO (CHCl3) 1700.8 cm-1; HRMS (EI) calcd for C16H16O2
(Mþ) 240.1150, found 240.1148.
2-Methylallyl 3-p-tolylpropiolate (19): 1H NMR (CDCl3, 500
MHz) δ 1.81 (s, 3 H), 2.36 (s, 3 H), 4.64 (s, 2 H), 4.99 (s, 1 H), 5.06
(s, 1 H), 7.17 (d, J = 7.9 Hz, 2 H), 7.47 (d, J = 7.9 Hz, 2 H); 13
C
NMR (CDCl3, 125 MHz) δ 19.3, 21.5, 68.9, 80.1, 86.9, 113.8,
116.3, 129.2, 132.8, 139.0, 141.2, 153.7; IR νCO (CHCl3) 1705.6
J. Org. Chem. Vol. 74, No. 20, 2009 7933